“…The stored data included age band, partial postcode, any recorded symptoms or clinical information, referral source, month of sample collection, and the results of other virological tests for each sample. For the samples from 2022, the majority were nose and throat swabs (117) with the remainder consisting of nasopharyngeal secretions (14), nose swabs (10), throat swabs (6), and bronchoalveolar lavage (BAL) (2). For the control cohort, the samples predominantly comprised nasopharyngeal aspirates or swabs (130/141) and were routinely screened for the following respiratory viruses by previously described polymerase chain reaction (PCR) assays 18,19 : AdV, influenza A and B viruses, parainfluenza virus type 1 (PIV-1), PIV-2, PIV-3, and respiratory syncytial virus (RSV).…”